SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-059440
Filing Date
2015-02-24
Accepted
2015-02-24 11:04:00
Documents
7
Period of Report
2015-02-24
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d880396d8k.htm 8-K 15549
2 EX-99.1 d880396dex991.htm EX-99.1 57494
3 GRAPHIC g880396ex99_1s1gbgd.jpg GRAPHIC 27686
4 GRAPHIC g880396ex99_1s2gbgd.jpg GRAPHIC 52005
5 GRAPHIC g880396ex99_1s3gbgd.jpg GRAPHIC 15993
6 GRAPHIC g880396ex99_1s4gbgd.jpg GRAPHIC 27761
7 GRAPHIC g880396ex99_1s5gbgd.jpg GRAPHIC 20631
  Complete submission text file 0001193125-15-059440.txt   273681
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 15642240
SIC: 2834 Pharmaceutical Preparations